Concepedia

OnabotulinumtoxinA for treatment of chronic migraine: PREEMPT 24-week pooled subgroup analysis of patients who had acute headache medication overuse at baseline

Stephen D. Silberstein, Andrew Blumenfeld, Roger Cady, Ira Turner, Richard B. Lipton, Hans‐Christoph Diener, Sheena K. Aurora, Mai D. Sirimanne, Ronald E. DeGryse, Catherine C. Turkel,

Journal of the Neurological Sciences · 2013 · 215 citations · 30 references

DOI

Concepts

References

30

The International Classification of Headache Disorders: 2nd edition

Jes Olesen, Peter J. Goadsby, Tim Steiner · The Lancet Neurology · 2003 · 5.1K citations

, , +13

A six-item short-form survey for measuring headache impact: The HIT-6™

Mark Kosinski, Martha Bayliss, John E. Ware et al. · Quality of Life Research · 2003 · 1.3K citations

, , +14

OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial

SK Aurora, DW Dodick, CC Turkel et al. · Cephalalgia · 2010 · 1K citations · Full text

, , +17

OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Results From the Double‐Blind, Randomized, Placebo‐Controlled Phases of the PREEMPT Clinical Program

David W. Dodick, Catherine C. Turkel, Ronald E. DeGryse et al. · Headache The Journal of Head and Face Pain · 2010 · 986 citations

, , +17

OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial

HC Diener, DW Dodick, SK Aurora et al. · Cephalalgia · 2010 · 953 citations

, , +17